Clinical study is promising for Type 1 diabetes patients
DENVER, Colorado (Press Release)– A clinical study on a promising treatment for Type 1 diabetes developed by a Ben-Gurion University of the Negev (BGU) researcher in collaboration with the University of Colorado Health Science Center had an “exceptional outcome” after an eight-week treatment of Alpha1-Antitrypsin (AAT). According to the study published in the Journal of
Clinical study is promising for Type 1 diabetes patients Read More »
Travel and Food






